Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients
- 1 August 2003
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (4) , 405-410
- https://doi.org/10.1038/sj.bmt.1704144
Abstract
We examined the incidence, risk factors and associated mortality of acute renal failure requiring dialysis (Renal Bearman Grade [BG] 3) in a 3-year cohort of 97 consecutive allogeneic blood and marrow transplantation (alloBMT) patients. In all, 20 (21%) developed Renal BG3 (all died by day +132) and 77 (79%) developed renal insufficiency (Renal BG1-2). Renal BG3 was a contributing or primary cause of death in 18 (90%) patients who continued to require dialysis at time of death. The two Renal BG3 patients whose deaths were not related to renal failure died on day +103 of hemorrhage and day +132 of underlying disease. By univariate analysis, age, unrelated donor, veno-occlusive disease (VOD) and grade III–IV acute graft-versus-host disease with hepatic involvement were significantly associated with Renal BG3. The multivariate model of time to Renal BG3 determined only a prior diagnosis of severe acute GVHD (RR=4.1, 95% CI 1.6–10.3, P=0.003) and VOD (RR=9.1, 95% CI 3.5–23.7, P<0.001) as significant independent predictors. Renal BG3 is generally considered a conditioning regimen-related toxicity. This study demonstrates that Renal BG3 is most commonly a complication of hepatic co-morbidities after allogeneic blood and marrow transplantation and identifies patients with a very poor prognosis.Keywords
This publication has 24 references indexed in Scilit:
- Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant GroupBone Marrow Transplantation, 2000
- Ciprofloxacin-associated acute renal failure in patients undergoing high-dose chemotherapy and autologous stem cell rescueBone Marrow Transplantation, 1998
- Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantationBone Marrow Transplantation, 1997
- THROMBOTIC MICROANGIOPATHIES ASSOCIATED WITH DRUGS AND BONE MARROW TRANSPLANTATIONHematology/Oncology Clinics of North America, 1996
- Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.Journal of Clinical Oncology, 1996
- Acute Renal Failure in Patients following Bone Marrow Transplantation: Prevalence, Risk Factors and OutcomeAmerican Journal of Nephrology, 1995
- Limited Tolerance of Intensified Conditioning Regimens in Children Receiving Methotrexate/Cyclosporin A for Graft-Versus-Host Disease ProphylaxisPediatric Hematology and Oncology, 1992
- Acute Renal Failure Following Bone Marrow Transplantation: A Retrospective Study of 272 PatientsAmerican Journal of Kidney Diseases, 1989
- Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromesBritish Journal of Haematology, 1983
- ACUTE RENAL TOXICITY WITH COMBINED USE OF AMPHOTERICIN B AND CYCLOSPORINE AFTER MARROW TRANSPLANTATIONTransplantation, 1983